284 related articles for article (PubMed ID: 21737500)
21. Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.
Gupta R; Srivastava P; Vardhan H; Salhan S; Mittal A
Reprod Biol Endocrinol; 2009 Apr; 7():38. PubMed ID: 19397832
[TBL] [Abstract][Full Text] [Related]
22. The Chlamydia-Secreted Protease CPAF Promotes Chlamydial Survival in the Mouse Lower Genital Tract.
Yang Z; Tang L; Shao L; Zhang Y; Zhang T; Schenken R; Valdivia R; Zhong G
Infect Immun; 2016 Sep; 84(9):2697-702. PubMed ID: 27382018
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a secreted Chlamydia protease.
Shaw AC; Vandahl BB; Larsen MR; Roepstorff P; Gevaert K; Vandekerckhove J; Christiansen G; Birkelund S
Cell Microbiol; 2002 Jul; 4(7):411-24. PubMed ID: 12102687
[TBL] [Abstract][Full Text] [Related]
24. Chlamydia trachomatis immune evasion via downregulation of MHC class I surface expression involves direct and indirect mechanisms.
Ibana JA; Schust DJ; Sugimoto J; Nagamatsu T; Greene SJ; Quayle AJ
Infect Dis Obstet Gynecol; 2011; 2011():420905. PubMed ID: 21747639
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis.
Massari P; Toussi DN; Tifrea DF; de la Maza LM
Infect Immun; 2013 Jan; 81(1):303-10. PubMed ID: 23132491
[TBL] [Abstract][Full Text] [Related]
26. Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions.
Kari L; Southern TR; Downey CJ; Watkins HS; Randall LB; Taylor LD; Sturdevant GL; Whitmire WM; Caldwell HD
Infect Immun; 2014 Jul; 82(7):2756-62. PubMed ID: 24733093
[TBL] [Abstract][Full Text] [Related]
27. Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm.
Lei L; Qi M; Budrys N; Schenken R; Zhong G
Microb Pathog; 2011 Sep; 51(3):101-9. PubMed ID: 21605656
[TBL] [Abstract][Full Text] [Related]
28. Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response.
Rajeeve K; Das S; Prusty BK; Rudel T
Nat Microbiol; 2018 Jul; 3(7):824-835. PubMed ID: 29946164
[TBL] [Abstract][Full Text] [Related]
29. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
Dai W; Li Z
Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
[TBL] [Abstract][Full Text] [Related]
30. Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2.
Kiselev AO; Skinner MC; Lampe MF
PLoS One; 2009; 4(4):e5191. PubMed ID: 19367336
[TBL] [Abstract][Full Text] [Related]
31. Persistence of Chlamydia trachomatis infections: bacterium and host based?
Morré SA; Spaargaren J; Schmid G; Peña AS; Coutinho RA
J Infect Dis; 2001 Dec; 184(12):1631-3. PubMed ID: 11740744
[No Abstract] [Full Text] [Related]
32. Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.
Brinkworth AJ; Malcolm DS; Pedrosa AT; Roguska K; Shahbazian S; Graham JE; Hayward RD; Carabeo RA
Mol Microbiol; 2011 Oct; 82(1):131-44. PubMed ID: 21883523
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
Fields KA; Hackstadt T
Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
[TBL] [Abstract][Full Text] [Related]
34. Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen.
O'Connell CM; Ionova IA; Quayle AJ; Visintin A; Ingalls RR
J Biol Chem; 2006 Jan; 281(3):1652-9. PubMed ID: 16293622
[TBL] [Abstract][Full Text] [Related]
35. Stromal Fibroblasts Drive Host Inflammatory Responses That Are Dependent on Chlamydia trachomatis Strain Type and Likely Influence Disease Outcomes.
Jolly AL; Rau S; Chadha AK; Abdulraheem EA; Dean D
mBio; 2019 Mar; 10(2):. PubMed ID: 30890604
[No Abstract] [Full Text] [Related]
36. Chlamydia trachomatis GlgA is secreted into host cell cytoplasm.
Lu C; Lei L; Peng B; Tang L; Ding H; Gong S; Li Z; Wu Y; Zhong G
PLoS One; 2013; 8(7):e68764. PubMed ID: 23894341
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Chlamydia trachomatis serovars in endocervical specimens derived from pregnant Japanese women.
Ikehata M; Numazaki K; Chiba S
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):35-41. PubMed ID: 10617788
[TBL] [Abstract][Full Text] [Related]
38. Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1.
Gong S; Lei L; Chang X; Belland R; Zhong G
Microbiology (Reading); 2011 Apr; 157(Pt 4):1134-1144. PubMed ID: 21233161
[TBL] [Abstract][Full Text] [Related]
39. Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway.
Chen D; Lei L; Lu C; Flores R; DeLisa MP; Roberts TC; Romesberg FE; Zhong G
Microbiology (Reading); 2010 Oct; 156(Pt 10):3031-3040. PubMed ID: 20522495
[TBL] [Abstract][Full Text] [Related]
40. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection.
Gérard HC; Freise J; Wang Z; Roberts G; Rudy D; Krauss-Opatz B; Köhler L; Zeidler H; Schumacher HR; Whittum-Hudson JA; Hudson AP
Microbes Infect; 2002 Jan; 4(1):13-22. PubMed ID: 11825770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
